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O B J E C T I V E S The purpose of this study was to compare carotid plaque burden, carotid intima-
media thickness (cIMT), ankle-brachial index (ABI), and abdominal aortic diameter (AAD) to coronary
artery calcium score (CACS) in people without known cardiovascular disease.
B A C KG ROUND The clinical utility of risk factors to predict cardiovascular events is limited. Detection of
subclinical atherosclerosis by noninvasive tests such as CACS, cIMT, carotid plaque burden, AAD, and ABI may
improve risk prediction above that of established risk scoring models, namely, Framingham Risk Score.
METHOD S The High Risk Plaque BioImage study investigated 6.101 asymptomatic persons and
reports baseline CACS, cIMT, ABI, and AAD. In addition, we present ﬁndings from a new 3-dimensional–
based ultrasound approach, where the carotid artery was investigated in cross section from proximal in
the neck to as distal as possible. From the resulting 10-s video, plaque was outlined on cross-sectional
images and all plaque areas were summarized into “plaque burden.”
R E S U L T S The mean age was 68.8 years, and 65.3% of subjects had intermediate Framingham Risk
Score (6% to 20% 10-year risk). Carotid plaques were identiﬁed in 78% of cases, abnormal ABI in 10%,
AAD 20 mm in 28%, and coronary calcium in 68% of participants. Carotid plaque burden was found
to correlate stronger with CACS (chi-square 450, p  0.0001) than did cIMT (chi-square 24, p  0.0001),
AAD (chi-square 2.9, p  0.091), and ABI (chi-square 35.2, p  0.0001).
CONC L U S I O N S In the BioImage study, a new 3-dimensional–based ultrasound method identiﬁed
more carotid plaques than in previous studies. Compared to other methods, carotid plaque burden was
the strongest cross-sectional predictor of CACS, and its clinical utility as predictor of future cardiovascular
events is being evaluated in the BioImage study. (BioImage Study: A Clinical Study of Burden of
Atherosclerotic Disease in an At-Risk Population; NCT00738725) (J Am Coll Cardiol Img 2012;5:681–9)
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682ausal risk factors for atherosclerotic car-
diovascular disease are known and consti-
tute important therapeutic targets, but
their usefulness as accurate predictors for
eveloping the disease is limited (1). Most heart
ttacks and strokes occur in people at average risk
actor level who are classified by traditional risk
actor scoring as low or intermediate risk (2).
onversely, others are misclassified as high risk and
istakenly advised to take drugs to reduce their risk
actors for the rest of their life. These facts remind
s that, although exposure to causal factors is impor-
ant, susceptibility to these factors and the disease in
uestion might be more important. Despite great
romise, genetic testing for susceptibility has not yet
roven useful for risk stratification (3). In contrast,
ests for subclinical atherosclerosis may provide prog-
ostic information beyond that provided by traditional
isk factor scoring alone (4). Subclinical atherosclerosis
can be detected and quantified noninva-
sively, to show the cumulative effect of all
risk and susceptibility factors combined—
known and unknown (5).
Noninvasive tests that have been shown
to correlate with cardiovascular outcomes
include coronary artery calcium score
(CACS) determined by computed tomog-
raphy (CT), carotid intima-media thick-
ness (cIMT), carotid plaque and abdomi-
nal aortic diameter (AAD) assessed by
ultrasound imaging, and the ankle-
brachial index (ABI) test (5–14).
The 2010 American College of Cardi-
ology Foundation/American Heart Asso-
iation guideline for cardiovascular risk assessment
ecommends (class IIa) use of CACS by CT, cIMT
nd carotid plaque by ultrasound, and ABI in
symptomatic adults at intermediate risk according
o traditional risk factor scoring (4).
The High Risk Plaque (HRP) BioImage study
as initiated to explore the predictive value of
oninvasive tests for detection and assessment of
ubclinical atherosclerosis and risk prediction. We
ntroduced a novel 3-dimensional (3D) carotid
ltrasound method to optimize detection of plaque
nd to quantify the amount of plaque (carotid
laque burden). This paper reports on the preva-
ence and severity of subclinical arterial disease in 4
ascular territories at baseline in the BioImage
tudy, focusing in particular on the ability to predict
oronary atherosclerosis (CACS) from measure-
ents performed in other arteries (cIMT, carotid
ium
ry
a
ylaque, ABI, and AAD). (M E T H O D S
The HRP BioImage study. The design and objectives
f the BioImage study (NCT00738725) have been
ublished in detail (15). In brief, the BioImage
tudy is investigating whether imaging of target
rteries for subclinical atherosclerosis and measure-
ent of ABI and circulating biomarkers add to the
redictive value of traditional risk factor scoring
ystems, namely, the Framingham Risk Score. This
opulation-based study is a prospective, combined
ross-sectional and longitudinal observational
tudy. The cross-sectional analyses, which pertain
o baseline findings, include the present study.
Enrollment in the BioImage study (January 2008
o June 2009) resulted in inclusion of 7,687 asymp-
omatic Americans ages 55 to 80 years from the
umana Health System resident in Chicago, Illi-
ois, or Fort Lauderdale, Florida. Of these, 6,104
ntered the imaging arm of the study. The BioIm-
ge study and method of selection and recruitment
as approved by the Western Institutional Review
oard, Olympia, Washington. All study partici-
ants provided written informed consent and
ealth Insurance Portability and Accountability
ct authorization before enrollment.
Baseline assessments. The baseline examination in-
cluded blood tests for risk factors, ultrasound im-
aging of the carotid arteries and infrarenal aorta,
ABI measurements, and CT for CAC scoring.
Selected participants underwent advanced imaging
as previously described (15).
Ultrasound imaging. Philips iU22 ultrasound systems
Philips Healthcare, Bothell, Washington) with vari-
us transducers were used for all studies. Four expe-
ienced registered vascular technologists performed all
maging studies unaware of findings from other im-
ging modalities. The scanning protocol included
tandard imaging of the carotid artery and its branches
sing generally accepted Doppler criteria for assess-
ent of any degree of narrowing (16).
Measurement of cIMT was performed off line
rom a 10-s video clip of the distal CCA recorded in
ongitudinal mode, ensuring the CCA was parallel
o the transducer surface (horizontal in the image).
ocal zone was set to the far CCA wall, and gain
as adjusted high enough so echoes were just
bserved in the lumen.
In addition, we introduced 3D imaging of the
arotid arteries to identify lesions located in the
ervical part of the CCA and internal carotid arteryA B B R E V I A T I O N S
A N D A C R O N YM S
AAD abdominal aortic
diameter
CACS coronary artery calc
score
CCA common carotid arte
cIMT carotid intima-medi
thickness
CT computed tomograph
MRImagnetic resonance
imaginginternal carotid artery). With the lack of fully developed
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6833D technology for carotid imaging at the start of the
study, assessment of plaque was undertaken using a
high-resolution, linear array 2-dimensional transducer
and scanning the artery in cross-section, slowly moving
the transducer manually in the cranial direction from
the proximal CCA into the distal internal carotid
artery (i.e., from the clavicle to jawbone). The speed of
the transducer was not controlled, but was assumed to
be relatively consistent from participant to participant,
on the basis of registered vascular technologist training
and the imaging protocol. The resulting 10-s digital
video clip of this “manual 3D” cross-sectional sweep
was examined in the core ultrasound laboratory for the
presence and quantification of plaque.
The infrarenal aorta was examined in cross-
section from the renal arteries to the aortic bifur-
cation, and 1 cross-sectional still image was re-
corded from the location with greatest diameter.
All ultrasound recordings were read in the core
laboratory at the Department of Vascular Sur-
gery, Rigshospitalet, University of Copenhagen
(Copenhagen, Denmark) using Philips QLAB
quantification software, which was enhanced with
specially developed, semiautomated plaque anal-
ysis software, QLAB-VPQ (vascular plaque
quantification) (Fig. 1). All core laboratory reads
were performed by blinded readers, using their
individual reading station and unaware of results
from other imaging modalities.
Carotid plaque presence and burden. Carotid plaque
was defined as local thickening of the cIMT of
50% compared to the surrounding vessel wall, an
IMT 1.5 mm, or local thickening 0.5 mm
(10,17). If plaque was identified when reviewing the
manual 3D sweep movies, the QLAB-VPQ plug-in
was used to outline vessel walls and residual lumen
in contiguous frames where plaque was present
(Fig. 1).
The total of all plaque areas from all images
showing plaque was defined as “carotid plaque
burden.” In case of bilateral or multiple unilateral
plaques, the sum of all areas of all plaques was
considered as the carotid plaque burden for the
patient, which was used for all analyses and com-
parisons in this study.
Interobserver variability was evaluated by 83
scans being read by both readers, each blinded from
the other’s findings.
Carotid IMT. Measurement of cIMT was performed
with Philips QLAB IMT plug-in, using the 10-s
video clips of the distal 10 mm of the CCA in
longitudinal view obtained from the lateral aspect of nthe neck. The reader selected frames with good
perpendicular alignment and image quality and
adjusted IMT box position if necessary to ensure
measurement of mean cIMT over the distal 10 mm
of the far wall of the CCA. For every participant, 5
to 10 mean IMT measurements were taken at the
same phase of the cardiac cycle (electrocardiography
gated) on each artery (right/left) for every partici-
pant. All cIMT measurements from both arteries
were averaged to create an IMT score.
Abdominal aortic diameter. The iU22 distance cali-
ers were placed at the anterior and posterior wall,
racking the outer vessel wall of the abdominal
orta. Because participants were not fasting, a
ubstantial number of cases (1.028 [16.8%]) had
nconclusive scans mainly due to bowel gas, al-
hough obesity also precluded usable scans in some.
Ankle-brachial index. After rest for 15 min and with
anual blood pressure cuff around the ankle, the
orsal pedal and posterior tibial arteries were iden-
ified using a hand-held Doppler device. Once
nsonated, the cuff was inflated until Doppler sig-
Figure 1. Images of Carotid Plaque Burden
Segment of carotid artery with a plaque (orange), which is scanned
linear array transducer as a series of image slices in transverse secti
Each image is analyzed with semiautomated software to quantify p
area, plaque grayscale statistics, percent stenosis, and other metrics
est. Plaque areas from all images in the entire image sequence wer
summed as “plaque burden.” (Lower left) Common carotid artery (
no plaque. The blue border represents the lumen/intima border; th
border represents the media–adventitia boundary. (Lower right) Co
carotid artery with plaque. The red border and blue border are the
in previous image, but the orange border represents the boundary
plaque.with a
on (top).
laque
of inter-
e
CCA) with
e red
mmon
same as
of theals disappeared and then slowly deflated until
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684Doppler signals were audible again. The test was
repeated 3 times for each of the 2 arteries on both
feet and an average blood pressure value for each
foot recorded.
For reference, blood pressures were measured on
both arms and the highest brachial artery blood
pressure was used for reference. The higher blood
pressure of the 2 arteries in 1 foot was used for the
limb ABI. The lower of 2 limbs ABI was used to
classify the participant.
Coronary artery calciﬁcation by CT. Noncontrast mul-
tidetector CT scans of the coronary arteries were
performed using Philips Brilliance 64-slice CT
with prospective electrocardiography-gated ac-
quisition. The average estimated radiation was
0.8 to 1.2 mSv. The CT scans were interpreted at
the CT core laboratory at Mount Sinai School of
Medicine (New York, New York) by board-
certified cardiologists or radiologists using Philips
EBW or Terarecon Advanced Workstations.
Coronary calcium was quantified according to the
Agatston method.
Statistical analysis. Power calculations for the BioIm-
age study were conducted to determine the number of
subjects required to detect imaging and/or circulating
biomarkers with incremental predictive value over
traditional cardiovascular risk factors (15).
For the purpose of this cross-sectional study, we
chose to compare the imaging methods and ABI
assessment to that of CACS, which has been shown
to provide incremental predictive information for
hard coronary heart disease endpoints. Ordinal
logistic regression was used to evaluate individually
the association of CACS individually with the
following 4 parameters: ABI, AAD, cIMT, and
carotid plaque burden. Separate regression models
were fit for each of these predictor variables. Cor-
onary artery calcium score, treated as the dependent
variable, was categorized into the 4 ordered catego-
ries of 0, 1 to 100, 101 to 400, and 400 (8,15).
Each predictor variable was treated as follows. The
ABI was dichotomized into 2 categories, 0.9 to 1.3
(normal), and 0.9 or 1.3 (abnormal). Abdomi-
nal aortic diameter and carotid IMT were treated as
untransformed, continuous variables. In a separate
analysis, carotid IMT was also considered as a
categorical variable, categorized into 4 categories by
quartiles of the distribution (0.65 mm, 0.65 to
0.73 mm, 0.74 to 0.83 mm, and 0.84 mm).
Carotid plaque burden was categorized into 4 cat-
egories, namely 0, and tertiles of the nonzero values
(as in Table 2). The chi-square values from the
Wald test are reported for the predictor variables. Ineach of the ordinal logistic regression models, only
subjects complete on CACS and on the predictor
variable of interest, and on all other covariates
considered in each model, were considered. Data
were available for 5,937 subjects for CACS, 6,090
for carotid plaque burden, 6,086 for cIMT, 6,042
for ABI, and 5,073 for AAD. The AAD variable,
considered in this study as a continuous variable,
exhibited no nonlinearity in association with
CACS, and as such no transformation was applied.
The intraclass correlation coefficient was calculated
to assess the measurement reproducibility of multiple
observers. Values of the intraclass correlation coefficient
range from 0 to 1, with values closer to 1 indicating
greater homogeneity. The intraclass correlation coeffi-
cient was calculated as described by Lohr (18).
No imputation of missing values was performed.
No adjustment for any putative outlier parameter
values was applied. All p values were 2-tailed. Statis-
Table 1. Baseline Observations
All Subjects
(n  6,101)
Age, yrs 68.8 6.0
Male 2,663 (43.6%)
Body mass index, kg/m2 29.1 5.6
Diabetes mellitus 950 (15.6%)
Current smoker 519 (8.5%)
Ethnicity
White 4,513 (74.0%)
Black 932 (15.3%)
Asian 122 (2.0%)
Hispanic 375 (6.1%)
Other 159 (2.6%)
Cholesterol, mg/dl
LDL-C 114.1 33.3
HDL-C 55.6 15.3
TC 202.5 38.7
TC:HDL-C ratio 3.85 1.12
Blood pressure, mm Hg
SBP 139.5 18.5
DPB 78.2 9.1
Renal insufﬁciency* 238 (3.9%)
Framingham 10-year CHD risk†
6% 1,251 (21.1%)
6%–20% 3,877 (65.3%)
20% 805 (13.6%)
Values are mean  1 SD or n (%). Continuous variables are compared using
Student t test or analysis of variance test for overall difference; categorical
variables are compared using the chi-square test. *Renal insufﬁciency if
creatinine 1.5 mg/dl for men, 1.3 mg/dl for women. †Using LDL-C FRS
score sheets (19). Evaluated on subjects complete on all Framingham Risk
Score parameters.
CHD  coronary heart disease; DBP  diastolic blood pressure; HDL-C 
high-density lipoprotein cholesterol; LDL-C  low-density lipoprotein choles-
terol; SBP  systolic blood pressure; TC  total cholesterol.
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685tical analyses were conducted with the use of SAS
software, version 9.0 (SAS Institute, Cary, North
Carolina), and R software, version 2.0 (R Foundation
for Statistical Computing, Vienna, Austria).
R E S U L T S
Of the 6,104 participants enrolled in the imaging arm
of the BioImage study, 3 were excluded because of
incomplete informed consent. Baseline characteristics
are shown in Table 1 (19). Most of the participants
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Figure 2. Distributions of Findings Using Different Imaging Mod
Whereas carotid intima-media thickness (cIMT), aortic diameter, and
Table 2. Findings in Each of the Imaging Modalities
CACS (N  5,937)
CACS 0 CACS 1–100
(n  1,904) (n  1,721)
Plaque burden (N  6,090)
No plaque on either carotid artery Tertile 1 (2.58
(n  1,360) (n  1,570)
Carotid intima-media thickness (N  6,086)
Quartile 1 Quartile 2
0.65 mm 0.65–0.73 mm
(n  1,449) (n  1,568)
Aortic diameter (N  5,073) 20 mm
(n  3,630)
ABI (N  6,042)
0–0.59 0.60–0.89
(n  36) (n  327)
ABI  ankle-brachial index; CACS  coronary artery calcium score.calcium (CAC) score, and carotid plaque burden were left skewed.ere white (74%) and belonged to the intermediate
isk category by Framingham Risk Score (65.3%).
here was a slight majority of women (56.4%).
Imaging data for comparisons were available in
,937 of cases for CACS, 6,090 for carotid plaque
urden, 6,086 for cIMT, 6,042 for ABI, and 5,073
or AAD.
Distributions of parameter variables derived us-
ng the various tests for subclinical arterial disease
re shown in Figure 2. The CACS and carotid
laque burden revealed left skewed distributions as
rden (cm2)
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ies and ABI Measurement
kle-brachial index (ABI) were normally distributed, coronary artery
CACS 101–400 CACS 400
(n  1,316) (n  996)
2) Tertile 2 (2.58–4.21 cm2) Tertile 3 (4.21 cm2)
(n  1,585) (n  1,575)
Quartile 3 Quartile 4
0.74–0.83 mm 0.84 mm
(n  1,496) (n  1,573)
20–25 mm
(n  1,330)
25 mm
(n  113)
0.90–1.29 1.30
(n  5,451) (n  228)e Bu
6
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686no calcium or no plaque would be “normal” whereas
cIMT, AAD, and ABI measurement were normally
distributed. A considerable number of participants
had positive findings (Table 2): 4,033 (68%) had
CACS0, and unilateral or bilateral carotid plaque
was found in 78% of participants. A normal AAD
was found in 3,630 (72%) whereas an aneurysm
(AAD 30 mm) was observed in 44 participants
(0.9%). The ABI assessment revealed 5,451 (90%)
of participants with observations within the normal
range (0.9 to 1.3) (Table 2).
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Findings in Different Imaging Methods and ABI Measurements
to CACS Groups
t) Carotid plaque burden. (Upper right) Carotid intima-media
cIMT). (Lower left) Abdominal aortic diameter. (Lower right)
hial index (ABI). CACS  coronary artery calcium score.
rdinal Logistic Regression Models Evaluating Association of Each
Model 0 Mode
Odds Ratio
(95% CI)
Wald Chi-
Square p Value n
Odds Ratio
(95% CI)
T3: 7.34 (6.36–8.47) 826.5 0.0001 5,927 T3: 5.37 (4.64–6.22)
T2: 3.63 (3.17–4.17) T2: 2.93 (2.55–3.38)
T1: 1.97 (1.71–2.26) T1: 1.79 (1.55–2.06)
1.37 (1.31–1.44) 158.7 0.0001 5,923 1.15 (1.10–1.21)
Q4: 2.49 (2.18–2.84) 202.1 0.0001 5,923 Q4: 1.55 (1.35–1.78)
Q3: 1.64 (1.44–1.88) Q3: 1.23 (1.08–1.41)
Q2: 1.97 (1.13–1.47) Q2: 1.15 (1.00–1.31)
1.30 (1.23–1.37) 94.5 0.0001 4,940 1.06 (1.01–1.13)
2.11 (1.80–2.48) 83.0 0.0001 5,879 1.78 (1.51–2.10)
el 1  model 0 adjusted for age and sex. Model 2  model 0 adjusted for age, sex
iabetes status, body mass index, and smoking status. Variables are deﬁned as disc
kle-brachial index (ABI) is relative to the category comprising values from 0.9 to
alcium score (CACS) (n  5,937) and also complete on the indicated imaging pa
cIMT  carotid intima-media thickness; Q  quartile.Among the imaging modalities and ABI, CACS
was most strongly associated with carotid plaque
burden (Fig. 3), also after adjustment for a full
complement of clinical characteristics comprising
sex, age, race, total cholesterol, high-density lipo-
protein cholesterol, systolic blood pressure, diastolic
blood pressure, diabetes status, body mass index,
and smoking status (fully adjusted parameter chi-
square value of 450.0, indicating a highly significant
model fit) (Table 3). The strength of the association
was also evidenced by the high odds ratios for the
categories of plaque burden reported in Table 3. For
example, compared to patients with no plaque
burden, patients in the highest category of plaque
burden had a 7.34 (95% CI: 6.36 to 8.47) times
greater odds of being in the highest category of
CACS (unadjusted), as opposed to in lower CACS
categories, than patients in the lowest category of
plaque burden (Table 3). By comparison, the
analogous odds ratio for patients in the highest
quartile of carotid IMT was substantially lower,
2.49 (95% CI: 2.18 to 2.84), indicating a weaker
association between high carotid IMT and high
CACS values. Carotid IMT (treated either as a
continuous or categorized variable) and ABI
(categorized as normal or abnormal) were com-
parable in their individual associations with
CACS (fully adjusted chi-square values of 24.0
[continuous] and 28.5 [categorized] for carotid
IMT, and 35.2 for ABI). The association of
AAD with CACS was attenuated upon adjust-
ment for the full set of clinical factors and was no
longer significantly associated with CACS in the
fully adjusted model.
ging Variable Individually With CACS
Model 2
ald Chi-
quare p Value n
Odds Ratio
(95% CI)
Wald Chi-
Square p Value
554.8 0.0001 5,898 T3: 4.79 (4.11–5.57) 450.0 0.0001
T2: 2.73 (2.36–3.15)
T1: 1.70 (1.47–1.96)
31.7 0.0001 5,894 1.14 (1.08–1.19) 24.0 0.0001
40.7 0.0001 5,894 Q4: 1.46 (1.27–1.69) 28.5 0.0001
Q3: 1.21 (1.05–1.39)
Q2: 1.13 (0.99–1.30)
4.8 0.029 4,916 1.05 (0.99–1.11) 2.9 0.091
47.8 0.0001 5,850 1.65 (1.40–1.95) 35.2 0.0001
, total cholesterol, high-density lipoprotein cholesterol, systolic blood pressure,
d in the Methods section. Categorical variable odds ratios are relative to lowest
nclusive. The number of subjects available (n) is the intersection of all subjects
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687Testing for interobserver variation of reading, the
intraclass correlation coefficient was 0.823 when
plotting the 2 readers’ findings of “plaque burden.”
Classifying cases into 4 groups—no plaque and
tertiles of quantified plaques—the kappa value was
0.55 comparing the 2 readers’ findings.
D I S C U S S I O N
The HRP BioImage study is the first large
population-based study to evaluate the presence and
severity of subclinical arterial disease in 4 different
vascular beds at the same baseline examination. A
novel 3D-based approach using ultrasound imaging
to quantify carotid plaque burden in the carotid
arteries was found to correlate more closely with
coronary atherosclerosis (CACS) than cIMT, ABI,
and AAD. That atherosclerosis is a generalized
disease was confirmed by investigating 4 different
vascular beds.
New approach to quantify atherosclerosis in carotid
arteries. Using a novel “manual 3D” ultrasound
approach to screen the carotid arteries to identify
atherosclerotic lesions, the prevalence of carotid
plaques was found to be 78%. This prevalence is
nearly 2-fold higher than what has been reported in
the literature (20–23). The higher prevalence in our
study likely reflects the systematic use of 3D ultra-
sound screening approach along the full length of
the accessible carotid arteries from the clavicle to
the jaw, but also to some extent that the participants
were older than average in the studies compared to.
The only study, which until now has reported
prevalence of carotid plaque near to what we found,
was a substudy of the Rotterdam Study. In this
older population, of whom not all were free from
clinical atherosclerosis, carotid plaque was identi-
fied in 67% (20). Our manual 3D approach to
carotid ultrasound scanning identified more athero-
sclerotic lesions than reported by others using reg-
ular 2-dimensional ultrasound. This original obser-
vation is supported by our findings in CACS, the
other imaging methods, and ABI measurement,
which are similar to those reported by other studies
with respect to subclinical atherosclerosis observed,
in a population with comparable Framingham Risk
Score (see following text).
Identifying carotid atherosclerotic lesions in the
majority of our subjects (78%), who were all free
from clinical atherosclerotic disease at the time of
investigations, raises the question of clinical rele-
vance. However, similar to coronary calcium, which
also could be detected in the majority of subjects, dwe think quantification is important. Therefore, we
summarized all measured plaque areas into plaque
burden, which revealed a large spread of observa-
tions. The hypothesis of quantification is, the
greater amount of atherosclerosis, the higher the
risk.
BioImage compared to other population-based
studies. With an average age of participants of 68.8
ears, we found coronary calcium of varying degrees
n 68% of participants. This finding, and the dis-
ribution between CACS groups, 0, 1 to 99, 100 to
99, and 400, corresponds well with what has
een reported in other studies investigating people
ithout known coronary heart disease, taking sex,
ge, and ethnicity of the investigated population
nto account (6,20,23–25). We identified 9.1%
aving abnormal ABI among the BioImage partic-
pants, 6% with ABI 0.9 and 3.1% with ABI
1.3. This also compares well with findings in
ther studies (12,13), again considering the popu-
ation investigated. The ABI captures later stages of
therosclerosis, since not only should plaque be
resent in the lower limb arteries, it should also
educe the residual lumen in the affected artery
ignificantly, combined with insufficient collateral
lood supply to keep resting circulation within
ormal range. A normal aorta was found in 72% of
ases whereas 26% had a diameter of 20 to 25 mm
nd 2% an AAD 25 mm. The Cardiovascular
ealth Study found 58% of participants to have
ortic diameter20 mm, 34% to be in the group 20
o 25 mm, and 8% to have an AAD 25% (14).
owever, the participants in the Cardiovascular
ealth Study were older as the average age was 75
ears compared to 68.8 years in our study. Aortic
neurismal disease is known to be a condition of the
lderly.
Subclinical arterial disease in noncoronary versus
coronary arteries. We found that carotid plaque
urden, quantified by ultrasonography as described
n this paper, was more strongly correlated to
ACS than any of the other tests used to assess
oncoronary arterial disease (cIMT, ABI, and
AD). It is assumed that in view of the perfor-
ance of CACS, this closer correlation will corre-
pond to improved risk prediction. As carotid
laque burden assesses findings ranging from no
laque to extremes, just like CAC assessment iden-
ifies persons with no calcium at one end of the
pectrum to persons with much calcium (400),
hat may not be surprising. However, considering
hat atherosclerosis is a systemic disease, namely,
eveloping in many vascular beds more or less
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688simultaneously, and that atherosclerotic plaques
develop from fatty streaks into complex plaques
where calcium eventually is deposited, it was inter-
esting to notice that in a considerable number of
participants with no coronary calcium, carotid
plaque was present. This finding represents early
stages of atherosclerosis development in the carotid
artery where the counterpart in the coronary arteries
have not reached the late stage where calcification
takes place, revealing a further potential of quanti-
fication of plaque by 3D ultrasound. That carotid
plaque quantification in this paper expressed as
carotid plaque burden correlates strongly with
CACS, and the fact that ultrasonography is nonin-
vasive and does not involve radiation suggests ad-
vantages of this novel method. Although with
methodological limitations, assessing plaque area in
2-dimensional carotid images has indicated the
potential of carotid plaque quantification. The
Tromsø Study showed that carotid plaque area was
a stronger predictor of first ever myocardial infarc-
tion than was cIMT (26). However, evaluation of
the true predictive potential of carotid plaque quan-
tification by 3D ultrasound awaits cardiovascular
endpoints in the BioImage and other studies. The
BioImage study is expected to report the first
outcomes analysis in 2012.
The poorer correlation of ABI and AAD with
CACS may not be surprising. As already noted,
reduced ABI is found in late stages of atheroscle-
rosis causing blood flow obstruction, thus, small
calcified plaques in the coronary arteries may well
be identified in patients with similarly nonobstruc-
tive lesions in the lower limbs. Similarly, aortic
dilation most often occurs in the elderly, so younger
persons with subclinical coronary calcification may
have normal aortic dimensions. Conversely, pa-
tients with low ABI and AADs 25 mm had high
calcium score: participants with ABI 0.9 on
average had average CACS of 444 compared to 216
in participants with normal ABI (0.9 to 1.3; p 
00001). Similarly, patients with AAD25 mm had
an average CACS of 654 as compared to 191
observed in patients with normal AAD (20 mm;
p  0.0001).
Study limitations. Even though CACS has been
hown to be a strong predictor of future cardiovas-ndpoint/gold standard for comparisons of imaging
ethods and ABI measurement does not necessar-
ly translate into clinical relevance. Because of the
anual nature of the cross-sectional sweep of the
arotid artery, plaque burden is an approximation of
he amount of atherosclerotic disease, and is not a
rue measurement of the plaque volume present.
onetheless, this approach is simple and may be
ufficient to categorize the amount of disease pres-
nt as none, minor, moderate, or severe. Factors
hat might influence acquisition of plaque burden
re speed of movement of the transducer when
erforming the carotid sweep and frame rate. Con-
erning changes in the latter, default depth was 4
m with which the majority of cases were examined.
hanging to 3 cm would result in a 9% increase in
rame rate whereas a change to a depth of 5 cm
ould result in a decrease of 6%. As mentioned
arlier in the discussion, full reproducibility will be
eported separately. Reproducibility of reading re-
ealed a fair kappa value for classifying into groups
f increasing plaque burden. The cIMT method
sed in the BioImage study included only acquisi-
ion from 1 angle of the distal CCA and seems
easonable and justified by recent observations
27,28) even though it does not follow “standard
rotocol” (10). However, rather than assessing IMT
n only 1 image, we assessed IMT in 5 different
mages from each CCA, to obtain a representative
alue from the distal 10 mm CCA segment.
C O N C L U S I O N S
We found carotid plaque burden correlated stronger
with coronary atherosclerosis (CACS) than did
cIMT, ABI, and AAD at baseline in the BioImage
study. Thus, 3D quantification of carotid plaque by
ultrasound may be a stronger predictor of athero-
sclerotic cardiovascular disease than the current
2-dimensional approach. However, the predictive
value of this novel approach remains unknown until
we have prospective outcome data.
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